An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM). For cervical cancer, 94% of deaths occur in low- and middle-income countries (350,000 women died in 2022). Ra ...

ARCHERY CI Ajay Aggarwal recently appeared on the Simply Oncology podcast to discuss AI radiotherapy planning and the ARCHERY trial:  "Join us as we tackle the topic of Artificial intelligence in Radiotherapy. This week we speak to the excellent Professor Ajay Aggarwal about the use of AI in radiotherapy planning. We discuss the international ARCHERY trial using an ...

The ARCHERY team are pleased to confirm the study has surpassed it's recruitment target of 990 participants (330 per tumour type)! Since recruiting the first participant in December 2023, our sites in India, Jordan, Malaysia and South Africa have worked hard to meet these targets and you can read more about the teams involved on our centres pages here.  You can see the progres ...

The ARCHERY team are delighted to share news on a presentation given by Dr Issa Mohamad, co-CI working on ARCHERY at King Hussein Cancer Center in Jordan, one of our recruiting sites. The presentation was given at the 4th Middle East Radiation Oncology Congress (MESTRO) and Dr Mohamad has also produced summaries on ARCHERY for Arabic newspapers to raise awareness of the study ...

📺 AI in Radiotherapy – The ARCHERY Study Don’t miss this short film produced by London School of Hygiene and Tropical Medicine, U. of London, featuring Ajay Aggarwal, Principal Investigator of the ARCHERY study. He explores how artificial intelligence (AI) could transform radiotherapy delivery, particularly in low and middle-income countries. Dr. Aggarwal highlights how in ...